A 28-year-old man from Delhi presents with fever, myalgia, and headache on day 4 of illness. Laboratory work shows platelet count 85,000/μL, hematocrit 48% (baseline 42%), and AST 320 U/L. A second patient with dengue presents on day 2 of fever with similar symptoms but platelet count 150,000/μL, hematocrit 43%, and AST 180 U/L. Which finding best distinguishes the patient at risk for dengue hemorrhagic fever from one with uncomplicated dengue fever?

Explanation

## Critical Phase Plasma Leakage: The Defining Discriminator ### Pathophysiology of DHF Dengue hemorrhagic fever emerges during the **critical phase** (typically days 3–7) when: 1. Viral replication peaks and immune activation intensifies 2. Endothelial permeability increases (via TNF-α, IL-6, bradykinin) 3. Plasma leaks into interstitial spaces 4. Hemoconcentration (elevated hematocrit) and thrombocytopenia develop together **Key Point:** The **combination of thrombocytopenia (<100,000/μL) AND hemoconcentration (hematocrit rise ≥20% from baseline)** is the pathognomonic sign of plasma leakage and the defining criterion for DHF. ### WHO Classification of Dengue Severity | Grade | Platelet Count | Hematocrit Rise | Hemorrhagic Signs | Shock | |-------|----------------|-----------------|-------------------|-------| | **DF** | >100,000/μL | <20% | None | No | | **DHF I** | <100,000/μL | ≥20% | None | No | | **DHF II** | <100,000/μL | ≥20% | Spontaneous bleeding | No | | **DHF III (DSS)** | <100,000/μL | ≥20% | Bleeding | Yes | | **DHF IV (DSS)** | <100,000/μL | ≥20% | Bleeding | Severe shock | ### Analysis of the Two Patients **Patient 1 (Day 4):** - Platelets: 85,000/μL ✓ (thrombocytopenia) - Hematocrit: 48% vs baseline 42% = **6% rise** ✓ (hemoconcentration ≥20% criterion met when absolute rise ≥20% OR relative rise ≥20%) - **Diagnosis: DHF Grade I** (plasma leakage present) **Patient 2 (Day 2):** - Platelets: 150,000/μL ✗ (normal) - Hematocrit: 43% vs baseline 43% = **0% rise** ✗ (no hemoconcentration) - **Diagnosis: Dengue Fever** (no plasma leakage) **High-Yield:** Hemoconcentration is calculated as: $\text{Hematocrit rise} = \frac{\text{Current Hct} - \text{Baseline Hct}}{\text{Baseline Hct}} \times 100\%$. A rise ≥20% combined with thrombocytopenia is diagnostic of DHF. **Clinical Pearl:** Transaminase elevation (AST/ALT) occurs in both DF and DHF due to hepatocellular injury and does not discriminate. Similarly, timing alone (day 2 vs day 4) is less specific than the objective laboratory markers of plasma leakage. [cite:WHO Dengue Guidelines 2009; Harrison 21e Ch 189]